How to read PRP research: lab studies, animal models and clinical trials
PRP evidence runs from cell studies to animal models to human trials. Each level answers different questions and has its own limits.

Key takeaways.
- PRP research runs along a continuum from cell studies to animal models to human trials.
- In vitro studies show mechanisms but cannot capture healing in a living organism.
- Animal models add tissue-level and safety data, but healing biology differs between species.
- Uncontrolled case series generate hypotheses and cannot prove causation.
- Randomized controlled trials give the highest level of evidence for a treatment effect.
- Check who was studied and how the PRP was prepared before applying a result.
In vitro studies
In vitro means in the laboratory, outside a living organism. These studies expose cells such as fibroblasts, chondrocytes or stem cells to PRP under controlled conditions. They allow precise study of cellular responses and molecular mechanisms.
Their limit is the same thing that makes them useful. A controlled dish cannot reproduce the complex environment of living tissue, so these studies cannot predict clinical responses on their own.
Animal models
Animal studies bridge the gap between the laboratory and human trials. They let researchers follow healing over time in intact tissue and assess biomechanical outcomes and possible adverse effects. Small animals such as rats and rabbits often provide the first evidence in a living system.
The main limitation is that healing biology differs between species. A result in an animal model is a reason to study something in humans, not evidence that it applies to them.
Clinical studies
Case series and observational studies often give the first clinical picture. They are uncontrolled, so improvements might reflect natural healing, placebo effects or other treatments. They are useful for generating hypotheses and documenting real-world use.
Randomized controlled trials (RCTs) assign participants at random to PRP or a control. This minimizes bias and allows direct comparison. The CONSORT 2025 statement provides a 30-item checklist for reporting a randomized trial.
Questions to ask of any PRP trial
Look at who was enrolled. Many trials exclude people with diabetes, obesity, a smoking history or multiple comorbidities, yet these patients are common in practice. A result in young athletes with acute injuries may not apply to older patients with degenerative conditions.
Look at how the PRP was prepared. Products differ between studies, so two PRP trials may not have tested the same thing.
Educational content for healthcare professionals. Not a treatment recommendation. PRP applications are considered off-label.
This guide covers the what and the why.
The how is taught live. The webinar and live training go deeper on:
- Critical appraisal of key PRP trials
- Evidence by indication
- Translating trial findings to real patients
- Outcome measures used in PRP research
Common questions.
What is the highest level of evidence for PRP?
Can lab or animal studies show that PRP works in patients?
Why is it hard to compare PRP trials?
Sources
- EQUATOR Network. "CONSORT 2025 Statement: updated guideline for reporting randomised trials." 2025.
- PMC. "Action of Platelet-Rich Plasma on In Vitro Cellular Bioactivity: More than Platelets." PMC10049396.
Keep reading.
PRP · 3 min read
PRP vs stem cells, exosomes, hyaluronic acid and corticosteroids
How PRP compares with stem cell therapies, exosomes, hyaluronic acid and corticosteroids in mechanism, complexity, evidence and regulatory status.
Start the lessonPRP · 3 min read
The future of PRP: what research is exploring next
PRP research is moving toward automated preparation, controlled-release scaffolds, combination approaches and personalization. All remain under study.
Start the lessonPRP · 3 min read
How strong is the evidence for PRP therapy?
PRP evidence ranges from well-studied uses to uses with little or negative data. Here is how the research is graded, and where PRP stands with the FDA and insurers.
Start the lessonReady for the hands-on detail?
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.